- 10 July 2025: Abstract submission opens
- 9 October 2025: Abstract submission closes
- 27 November 2025: Abstract notifications sent to authors
Submission Categories
Subject areas:
1. Acquired bleeding disorders and complex coagulation disorders
2. Antithrombotic treatment
3. Arterial thromboembolism
4. Coagulation and fibrinolysis
5. Crosstalk between hemostasis and other systems
6. Diagnostics and laboratory tests
7. Haemophilia
8. von Willebrand Disease and other hereditary bleeding disorders
9. In vitro and in vivo models of hemostasis
10. Drug development and Innovative treatment methods
11. Platelets
12. Biology and diseases of the vascular system
13. Venous thromboembolism / Thrombophilia
14. Miscellaneous
Abstract Guidelines
- Abstract text is limited to 3,000 characters including spaces
- Submission language is English
- Please structure your abstract as follows:
- Introduction
- Method
- Results
- Conclusion
- Conflict of interest
- References
- You can upload up to two items (table and/or image) to your abstract.
- Please choose 1 of the subject areas for your abstract
- Please choose at least 1 and up to 3 interdisciplinary area items for your abstract.
- Encore abstracts are allowed.
- Please check spelling and grammar carefully. All abstracts will be published as submitted
- Use generic names. Commercial drug names may not be used
- Please note, the presenting author will need to be registered and attending GTH 2026.